Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

Publication Date

9-8-2023

Presented At:

EANO 2023 Annual Meeting

Content Type

Presentation

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS